News & Events

LabGenius Therapeutics Wired
August 9, 2023

Article | AI is Building Highly Effective Antibodies That Humans Can’t Even Imagine

LabGenius Therapeutics in Business of Biotech
July 7, 2023

Podcast | LabGenius’ CEO, James Field, discusses ML-enabled drug discovery as a recent guest on the Business of Biotech podcast

May 15, 2023

Press release | LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark